טוען...
TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma
TRAP1 is a HSP90 molecular chaperone upregulated in colorectal carcinomas and involved in control of intracellular signaling, cell cycle, apoptosis and drug resistance, stemness and bioenergetics through co-traslational regulation of a network of client proteins. Thus, the clinical significance of T...
שמור ב:
הוצא לאור ב: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Impact Journals LLC
2017
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5400579/ https://ncbi.nlm.nih.gov/pubmed/28177905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15070 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|